TL 383 TL 383 (Terazosin Hydrochloride 1 mg)
Pill with imprint TL 383 TL 383 is Gray, Capsule-shape and has been identified as Terazosin Hydrochloride 1 mg. It is supplied by Cadista.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TL 383 TL 383
Terazosin Hydrochloride
- Imprint
- TL 383 TL 383
- Strength
- 1 mg
- Color
- Gray
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, peripherally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadista
- Inactive Ingredients
-
ferrosoferric oxide,
gelatin,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
corn starch,
silicon dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 59746-0383 | Jubilant Cadista Pharmaceuticals Inc. |
| 67544-0581 | Prepak Systems Inc. (repackager) |
Related Images for "TL 383 TL 383"
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: antiadrenergic agents, peripherally acting
- FDA Alerts (1)
Consumer resources
- Other brands
- Hytrin
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.